Fuhrman grade and concomitant bisphosphonates as additional prognostic factors in metastatic renal cell carcinoma with bone metastases treated with sunitinib

被引：2
|
作者：
Beuselinck, B. L.
Medioni, J.
Wolter, P.
Blesius, A.
Karadimou, A.
Schbffski, P.
Escudier, B. J.
Zucman-Rossi, J.
Paridaens, R.
Oudard, S.
机构：
[1] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium
[2] Georges Pompidou European Hosp, Dept Med Oncol, Paris, France
[3] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.388
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
388
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    Motzer, R. J.
    Escudier, B.
    Bukowski, R.
    Rini, B. I.
    Hutson, T. E.
    Barrios, C. H.
    Lin, X.
    Fly, K.
    Matczak, E.
    Gore, M. E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2470 - 2477
  • [2] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    R J Motzer
    B Escudier
    R Bukowski
    B I Rini
    T E Hutson
    C H Barrios
    X Lin
    K Fly
    E Matczak
    M E Gore
    British Journal of Cancer, 2013, 108 : 2470 - 2477
  • [3] Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
    Bolzacchini, Elena
    Giordano, Monica
    Bertu, Lorenza
    Bregni, Marco
    Nigro, Olga
    Galli, Luca
    Antonuzzo, Andrea
    Artale, Salvatore
    Barzaghi, Sabrina
    Danova, Marco
    Torchio, Martina
    Pinotti, Graziella
    Dentali, Francesco
    TUMORI JOURNAL, 2022, 108 (05): : 502 - 509
  • [4] Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma
    Yildiz, I.
    Sen, F.
    Kilic, L.
    Ekenel, M.
    Ordu, C.
    Kilicaslan, I.
    Darendeliler, E.
    Tunc, H. M.
    Varol, U.
    Bavbek, S.
    Basaran, M.
    CURRENT ONCOLOGY, 2013, 20 (06) : E546 - E553
  • [5] Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
    B Beuselinck
    P Wolter
    A Karadimou
    R Elaidi
    H Dumez
    A Rogiers
    T Van Cann
    L Willems
    J-J Body
    J Berkers
    H Van Poppel
    E Lerut
    P Debruyne
    R Paridaens
    P Schöffski
    British Journal of Cancer, 2012, 107 : 1665 - 1671
  • [6] Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
    Beuselinck, B.
    Wolter, P.
    Karadimou, A.
    Elaidi, R.
    Dumez, H.
    Rogiers, A.
    Van Cann, T.
    Willems, L.
    Body, J-J
    Berkers, J.
    Van Poppel, H.
    Lerut, E.
    Debruyne, P.
    Paridaens, R.
    Schoffski, P.
    BRITISH JOURNAL OF CANCER, 2012, 107 (10) : 1665 - 1671
  • [7] Sunitinib in Metastatic Renal Cell Carcinoma Patients With Brain Metastases
    Gore, Martin E.
    Hariharan, Subramanian
    Porta, Camillo
    Bracarda, Sergio
    Hawkins, Robert
    Bjarnason, Georg A.
    Oudard, Stephane
    Lee, Se-Hoon
    Carteni, Giacomo
    Nieto, Alejandra
    Yuan, Jinyu
    Szczylik, Cezary
    CANCER, 2011, 117 (03) : 501 - 509
  • [8] Bisphosphonates in patients with renal cell carcinoma and bone metastases: a sunitinib global expanded-access trial subanalysis
    Vrdoljak, Eduard
    Gore, Martin
    Leyman, Sophie
    Szczylik, Cezary
    Kharkevich, Galina
    Schoffski, Patrick
    Torday, Laszlo
    Mardiak, Josef
    Zhang, Ke
    Sajben, Peter
    Sella, Avishay
    FUTURE ONCOLOGY, 2015, 11 (20) : 2831 - 2840
  • [9] Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Bukowski, Ronald M.
    Figlin, Robert A.
    Hutson, Thomas E.
    Michaelson, M. Dror
    Kim, Sindy T.
    Baum, Charles M.
    Kaftan, Michael W.
    CANCER, 2008, 113 (07) : 1552 - 1558
  • [10] Efficacy of Sunitinib in Patients with Renal Cell Carcinoma with Bone Metastases
    Paule, Bernard
    Brion, Nathalie
    ANTICANCER RESEARCH, 2010, 30 (12) : 5165 - 5168
12345